Skip to main content

Table 1 Patient clinical data

From: MAFLD with central obesity is associated with increased risk of colorectal adenoma and high-risk adenoma

Characteristic

Colorectal adenoma (n = 593)

Control (n = 802)

P

Sex (Male/Female)

376/217

489/313

0.355

Age

57 (46, 66)

52 (44, 60)

< 0.001

BMI

25.7 (24.6, 26.8)

24.5 (23.5, 25.5)

< 0.001

Waist circumference (cm)

85.6 (80.9, 90.5)

80.8 (77.0, 86.1)

< 0.001

Triglyceride (mg/dL)

126.0 (105.2, 143.1)

98.7 (75.8, 119.6)

< 0.001

HDL-cholesterol (mg/dL)

46.6 (40.6, 51.7)

56.3 (52.1, 60.4)

< 0.001

Fasting glucose (mg/dL)

100.0 (94.4, 105.0)

95.8 (90.0, 101.0)

< 0.001

Hypertension (%)

200 (33.7%)

137 (17.1%)

< 0.001

Diabetes

141 (23.8%)

41 (5.1%)

< 0.001

Obesity

381 (64.2%)

300 (37.4%)

< 0.001

Central obesity

168 (28.3%)

47 (5.9%)

< 0.001

Smoking

124 (20.9%)

95 (11.8%)

< 0.001

Fatty liver

341 (57.5%)

286 (35.6%)

0.005

  1. The Z test was used to compare proportions of two independent samples. The Mann‒Whitney U test was used to compare nonnormally distributed continuous variables